RECHEM
Welcome to our website!|Hot Line: 86-21-31433387|E-mail: sales@rechemscience.com
Products Category
Contact Us
| Tel: | +86-21-31433387 |
| +86-15618786686 | |
| Email: | sales@rechemscience.com |
| info@rechemscience.com | |
| QQ: | 1369748377 |
| Skype: | sales@rechemscience.com |
| Cat.No. | Product name | Product Description |
| R10766 | SC-202671 | JNK inhibitor IX is a selective and potent JNK inhibitor with pIC50 of 6.5 and 6 |
| R10777 | bml-210 | BML-210 is the novel HDAC inhibitor, and its mechanism of action has not been ch |
| R10778 | Pimelic diphenylamide 106; TC-H106 | Pimelic diphenylamide 106 is a slow, tight-binding inhibitor of class I HDAC (HD |
| R10779 | UF010 | UF010 is a potent and selective HADC inhibitor with IC50 ~0.06 μM, 0.1 μM, 0.5 μ |
| R10780 | KC7F2 | KC7F2 is a potent HIF-1 pathway inhibitor and that its potential as a cancer the |
| R10781 | WDR50103 | WDR5-0103 is a potent and selective WD repeat-containing protein 5 (WDR5) antago |
| R10793 | (-)-JQ1 | The bromodomain and extra terminal domain (BET) family of proteins, including BR |
| R10803 | PX478 dihydrochloride | PX-478 2HCl is an orally active, and selective hypoxia-inducible factor-1α (HIF- |
| R10835 | Birabresib (Synonyms: OTX-015; MK-8628) | OTX015 is a potent BET bromodomain inhibitor with EC50 ranging from 10 to 19 nM |
| R10886 | Domatinostat (4SC-202 free base) | Domatinostat (4SC-202 free base) is a selective class I HDAC inhibitor with IC50 |
| R10845 | Veliparib;ABT-888 | Veliparib (ABT-888) is a potent inhibitor of PARP1 and PARP2 with Ki of 5.2 nM a |
| R10903 | CEP-33779 | CEP33779 is a selective JAK2 inhibitor with IC50 of 1.8 nM, >40- and >800- |
| R10915 | GSK3235025;EPZ-015666;GSK-3235025 | EPZ015666 is a potent, selective and orally bioavailable PRMT5 inhibitor with Ki |
| R10925 | ML324 | ML324 is a selective inhibitor of jumonji histone demethylase (JMJD2) with IC50 |
| R10929 | UNC1215 | UNC1215 is a potent and selective MBT (malignant brain tumor) antagonist, which |
| R10978 | BIX-01294 | BIX01294 is an inhibitor of G9a histone methyltransferase with IC50 of 2.7 μM in |
| R10981 | UNC0379 | UNC0379 is a selective, substrate competitive inhibitor of N-lysine methyltransf |
| R10989 | SGC707 | SGC707 is a potent, selective and cell-active allosteric inhibitor of protein ar |
| R10990 | SP2509 | SP2509 is a selective histone demethylase LSD1 inhibitor with IC50 of 13 nM, sho |
| R11000 | Baricitinib phosphate;LY3009104 phosphate; INCB028050 phosphate | Baricitinib (LY3009104, INCB028050) is a selective JAK1 and JAK2 inhibitor with |
| R11001 | LY2784544 | Gandotinib (LY2784544) is a potent JAK2 inhibitor withIC50 of 3 n |
| R11453 | JNJ26854165;Quisinostat 2HCl | Quisinostat (JNJ-26481585) 2HCl is a novel second-generation HDAC inhibitor with |
| R11471 | GLPG0634 analog | GLPG0634 analogue is a selective JAK1 inhibitor with IC50 of 10 nM, 28 nM, 810 n |
| R11501 | Panobinostat (LBH589; NVP-LBH589) | Panobinostat (LBH589) is a novel broad-spectrum HDAC inhibitor with IC50 of 5 nM |
| R11530 | RG2833 (RGFP109) | RG2833 (RGFP109) is a brain-penetrant HDAC inhibitor with IC50 of 60 nM and 50 n |
